| Product NDC: | 13668-004 | 
| Proprietary Name: | Sertraline hydrochloride | 
| Non Proprietary Name: | Sertraline hydrochloride | 
| Active Ingredient(s): | 25 mg/1 & nbsp; Sertraline hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 13668-004 | 
| Labeler Name: | Torrent Pharmaceuticals Limited | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077765 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20070905 | 
| Package NDC: | 13668-004-30 | 
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (13668-004-30) | 
| NDC Code | 13668-004-30 | 
| Proprietary Name | Sertraline hydrochloride | 
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (13668-004-30) | 
| Product NDC | 13668-004 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Sertraline hydrochloride | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20070905 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Torrent Pharmaceuticals Limited | 
| Substance Name | SERTRALINE HYDROCHLORIDE | 
| Strength Number | 25 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |